HKPD Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 1.88
- P/S (TTM)
- 0.56
- EV/EBITDA
- 21.88
Profitability & growth
- ROE (TTM)
- -13.4%
- Operating margin
- 3.0%
- Revenue growth YoY
- -35.7%
- Dividend yield
- —
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
45 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Company profileHong Kong Pharma Digital Technology Holdings Limited is a pioneering entity in the biotechnology and digital healthcare sectors, focused on enhancing patient outcomes through innovative pharmaceutical services. By harnessing cutting-edge digital technologies and sophisticated data analytics, the company optimizes drug development and boosts operational efficiencies, positioning itself as a key player in the dynamic healthcare landscape. With a commitment to health technology advancement and strategic collaborations, Hong Kong Pharma is well-equipped to meet the evolving needs of both domestic…
Classification
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- WELL TOWN INDUSTRIAL BUILDING, YAU TONG, HONG KONG
- Fiscal year end
- March
- Latest quarter
- Jun 30, 2025
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
